Director of the UK Dementia Research Institute
An exciting and unique opportunity to lead the UK’s foremost biomedical research institute dedicated to neurodegenerative diseases. Applications due 13 March.
Read more
Genetics, microglia and complement: fourth round of cross-centre postdocs announced
We are delighted to announce the latest recipients of our cross-centre postdoctoral awards – a scheme designed to stimulate exciting new academic relationships and encourage collaboration between researchers across our seven centres.
Read more
ALS/MND research at UK DRI
Amyotrophic Lateral Sclerosis (ALS), or Motor Neurone Disease (MND), is a fatal neurodegenerative condition that causes progressive weakness of the muscles due to the degeneration of motor neurones in the brain and spinal cord. Many of our pioneering research programmes are committed to finding much-needed treatments for those people affected now and in the future.
Read more
“I'm not going to give up”: in conversation with 2022 MRC Millennium Medal winner Prof Sarah Tabrizi
For her outstanding efforts and achievements, Prof Tabrizi is recognised with this year’s prestigious MRC Millennium Medal. We caught up with Sarah to reflect on her career to date, passion for scientific investigation and tireless drive to deliver a cure for her patients at the National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH.
Read more
Building connections across the dementia ecosystem
The Dementia UK Ecosystem (DUKE) brings together leaders from the UK DRI, Dementias Platform UK, the National Institute for Health Research, the pharmaceutical industry, and funders to create a cohesive community, coordinating efforts to accelerate progress in tackling dementia.
Read more
Get involved in dementia research
Group Leader Dr Nir Grossman (UK DRI at Imperial) is leading a new trial using deep electrical currents applied to the brain of people living with Alzheimer's disease. The team are recruiting participants over the next year.
Read more
Turning breakthroughs into treatments
We have a clearly defined vision at the UK DRI to develop effective therapeutics, diagnostics and technologies for people living with dementia. Alongside building our disease knowledge over the coming years, we will also make progress in translating these discoveries into the clinic.
Translation and innovation
Our priorities as a research institute
We accelerate, innovate, deepen and broaden discovery science in dementia, with the goal of filling the huge knowledge gap in this field. We exist to bring forward the day when research benefits people living with and those at risk of dementia.
Read our science vision
Collaboration and connection
Our efforts to increase the diversity of our team, ensure inclusion and promote equality of opportunity, align with our vision for the UK DRI’s Institute culture and identity as a world-leader in dementia research.
Equity, Diversity and Inclusion
Bringing together researchers to address major scientific questions
We study a range of neurodegenerative disorders that cause dementia. Many of them share fundamental disease mechanisms and characteristics, and greater understanding gained in one can often benefit others. To ensure we capitalise on diverse expertise, approaches and perspectives, we have established cross-centre themes.
Research themes
